The Peter Attia Drive cover image

#194 - How fructose drives metabolic disease | Rick Johnson, M.D.

The Peter Attia Drive

00:00

Exploring the Future of Fructokinase Inhibitors in Treating Metabolic Disorders

This chapter explores the emerging role of fructokinase inhibitors in treating obesity, type 2 diabetes, and non-alcoholic fatty liver disease. It highlights the progress made in clinical trials, as well as the hurdles faced by pharmaceutical companies in bringing these innovations to market.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app